Expect heavy selling pressure as shares are issued at a slight discount and warrants provide further overhang. Monitor for the registration statement filing and potential near-term dilution. The 60-day equity issuance ban may provide temporary relief, but the overhang remains.
Price Chart
Executive Summary
GeoVax Labs entered into a securities purchase agreement to sell common stock at $1.48 per share and issue Series A (5-year) and Series B (18-month) warrants for 100% coverage at the same exercise price, alongside pre-funded warrants. The proceeds will fund working capital and general corporate purposes. This represents a significant dilutive event for the $8M market cap biotech, likely increasing share count substantially.
Key Facts
- Shares sold at $1.48 per share in a private placement
- Series A warrants (5-year term) and Series B warrants (18-month term) issued at $1.48 exercise price for 100% coverage
- Pre-funded warrants also available at $1.4799 per share
- Placement agent: A.G.P./Alliance Global Partners
- Proceeds used for working capital and general corporate purposes
- Company waived lock-up restrictions from prior May 7, 2026 warrant inducement letters
- Registration statement for resale of shares and warrant shares to be filed within 15 days
- 60-day ban on further equity issuances (except exempt issuances)
Financial Impact
Dilutive offering for an $8M market cap biotech; exact proceeds not disclosed but likely material relative to current capitalization.
Risk Factors
- Significant dilution from share issuance and potential warrant exercise
- Low market cap and cash burn rate increase going-concern risk
- Warrant overhang could cap any upside
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001437749-26-017809 |
| Exhibit: ex_965357.htm | 0001437749-26-017809 |
| Exhibit: ex_965356.htm | 0001437749-26-017809 |
| Exhibit: ex_965355.htm | 0001437749-26-017809 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 8-K | $0.2032 | awaiting T+60 | — | $0.2012 (+0.98%) |
Sep 24, 2026 4w ago | EFFECT | $0.3603 | awaiting T+60 | — | $0.2012 (+44.16%) |
Jun 4, 2026 20w ago | EFFECT | $1.79 $0.7210 | ▲ +59.72% | ▲ +61.60% | $0.2012 (+88.76%) |
May 26, 2026 22w ago | S-1 | $3.49 $0.5947 | ▼ −82.96% | ▼ −85.68% | $0.2012 (−94.23%) |
May 19, 2026 22w ago | 8-K | $2.23 $0.7180 | ▲ +67.80% | ▲ +72.81% | $0.2012 (+90.98%) |
May 14, 2026 23w ago | 8-K | $1.23 $0.7700 | ▲ +37.40% | ▲ +41.91% | $0.2012 (+83.64%) |
May 7, 2026 24w ago | 8-K | $1.67 $0.7620 | ▲ +54.37% | ▲ +59.21% | $0.2012 (+87.95%) |
Apr 22, 2026 26w ago | EFFECT | $1.17 $0.9742 | ▼ −16.73% | ▼ −21.51% | $0.2012 (−82.80%) |
Apr 20, 2026 27w ago | EFFECT | $1.17 $1.01 | ▲ +13.68% | ▲ +20.45% | $0.2012 (+82.80%) |
Apr 15, 2026 27w ago | 8-K | $1.23 $1.11 | ▲ +9.76% | ▲ +16.80% | $0.2012 (+83.64%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers